Indonesia

Healthcare, particularly in remote areas, is difficult to access for many Indonesians due to limited infrastructure, while the death of some 950 doctors and nurses during the pandemic due to limited quantities of personal protective equipment for healthcare providers has created a shortage of medical personnel. 

Nevertheless, COVID-19 saw the acceleration of telemedicine as the government simplified regulations and kickstarted local manufacturing of products to allow services to reach the population faster.

We took the initiative to bring in COVID-19 tests before the government announced the pandemic in March 2020, to ensure adequate supplies were available ahead of time. Our contributions also included building industry testing capability. We worked with the Ministry of Health, Ministry of State-owned Enterprises, COVID-19 National Task Force, and molecular biology research centre Eijkman Institute to provide COVID-19 testing in national COVID-19 management sites.

Strengthening Indonesia’s Medtech industry

• We are supporting associations such as the Asia Pacific Medical Technology Association (APACMed) and Gakeslab Indonesia, to advocate for industry-wide digitalisation and simplification of procurement systems to improve Indonesia’s overall healthcare scene.

Raising 246 Million Rupiah for critically ill children

• To increase access to healthcare for children in need, 100 Roche Diagnostics Indonesia employees and their families raised over 246 million rupiah through the Roche Children’s Walk – 76% more than the previous year – in support of Rumah Harapan Indonesia, a shelter for underprivileged children with critical illnesses.

Boosting healthcare access

• Through training programs and talks, we engaged healthcare stakeholders to address access to affordable, safe, and high-quality products.